Evaluation of the Meridian Premier EHEC assay as an indicator of Shiga toxin presence in direct faecal specimens

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 4, 2012, Pages 322-325

  Staples, Megan ^a   Jennison, Amy V ^a   Graham, Rikki M A ^a   Smith, Helen V ^a  

^a QUEENSLAND HEALTH   (Australia)

Author keywords

Premier EHEC EIA; Shiga toxigenic Escherichia coli (STEC); Shiga toxin; Vero cell

Indexed keywords

SHIGA TOXIN;

ACCURACY; ARTICLE; ASSAY; BACTERIUM DETECTION; CALCULATION; CONTROLLED STUDY; CYTOTOXICITY TEST; FECES ANALYSIS; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MERIDIAN ASSAY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; VERO CELL;

ANIMALS; BACTERIOLOGICAL TECHNIQUES; CELL CULTURE TECHNIQUES; CERCOPITHECUS AETHIOPS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; SHIGA TOXIN; VERO CELLS;

EID: 84863784458     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.05.004     Document Type: Article

References (23)

1. al-Jumaili I., Burke D.A., Scotland S.M., al-Mardini H., Record C.O. A method of enhancing verocytotoxin production by Escherichia coli. FEMS Microbiol Lett 1992, 72:121-125.
2. Beutin L., Zimmermann S., Gleier K. Pseudomonas aeruginosa can cause false-positive identification of verotoxin (Shiga-like toxin) production by a commercial enzyme immune assay system for the detection of Shiga-like toxins (SLTs). Infection 1996, 24:267-268.
3. Carpenter A.B. Immunoassays for the diagnosis of infectious diseases. Manual of Clinical Microbiology 2007, 1:257. ASM Press, Washington, DC. 9th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.L. Landry, M.A. Phaller (Eds.).
4. Centers for Disease Control and Prevention (CDC) University outbreak of calicivirus infection mistakenly attributed to Shiga toxin-producing Escherichia coli O157:H7 - Virginia, 2000. MMWR 2001, 50:489-491.
5. Centers for Disease Control and Prevention (CDC) Recommendations for diagnosis of shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR 2009, 58.
6. Holland J.L., Louie L., Simor A.E., Louie M. PCR detection of Escherichia coli O157:H7 directly from stools: evaluation of commercial extraction methods for purifying fecal DNA. J Clin Microbiol 2000, 38:4108-4113.
7. Karch H., Meyer T., Russmann H., Heesemann J. Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect Immun 1992, 60:3464-3467.
8. Karmali M.A. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989, 2:15-38.
9. Kehl K., Havens P., Behnke C., Acheson D. Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J Clin Microbiol 1997, 35:2051-2054.
10. Klein E.J., Stapp J.R., Clausen C.R., Boster D.R., Wells J.G., Qin X., et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. JPediatr 2002, 141:172-177.
11. Konowalchuk J., Speirs J.I., Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977, 18:775-779.
12. Mackenzie A.M.R., Lebel P., Orrbine E., Rowe P.C., Hyde L., Chan F., et al. Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotoxin (shiga-like toxin)-producing Escherichia coli. JClin Microbiol 1998, 36:1608-1611.
13. Maldonado Y., Fiser J.C., Nakatsu C.H., Bhunia A.K. Cytotoxicity potential and genotypic characterization of Escherichia coli isolates from environmental and food sources. Appl Environ Microbiol 2005, 71:1890-1898.
14. Meridian Bioscience I. Premier EHEC ELISA Product insert 2011, Meridian Bioscience, Inc., Cincinnati, OH.
15. Novicki T.J., Daly J.A., Mottice S.L., Carroll K.C. Comparison of sorbitol macconkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli. J Clin Microbiol 2000, 38:547-551.
16. Park C.H., Kim H.J., Hixon D.L. Importance of testing stool specimens for shiga toxins. J Clin Microbiol 2002, 40:3542-3543.
17. Paton A.W., Paton J.C. Direct detection and characterization of shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. J Clin Microbiol 2002, 40:271-274.
18. Ramotar K., Henderson E., Szumski R., Louie T. Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli. J Clin Microbiol 1995, 33:1114-1120.
19. Remis R.S., MacDonald K.L., Riley L.W., Puhr N.D., Wells J.G., Davis B.R., et al. Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med 1984, 101:624-626.
20. Roberts P.H., Davis K.C., Garstka W.R., Bhunia A.K. Lactate dehydrogenase release assay from Vero cells to distinguish verotoxin producing Escherichia coli from non-verotoxin producing strains. J Microbiol Methods 2001, 43:171-181.
21. Roche D.A.P.L. Cytotoxicity Detection Kit (LDH) product insert 2011, Roche Diagnostics Australia Pty Ltd, Castle Hill, NSW.
22. Tarr P.I., Neill M.A., Clausen C.R., Watkins S.L., Christie D.L., Hickman R.O. Escherichia coli 0157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis 1990, 162:553-556.
23. Viera A.J., Garrett J.M. Understanding interobserver agreement: the kappa statistic. Fam Med 2005, 37:360-363.